BODY TEMPERATURE LOWERING AGENT, BODY TEMPERATURE ELEVATION SUPPRESSOR, FOOD COMPOSITION FOR LOWERING BODY TEMPERATURE,AND FOOD COMPOSITION FOR SUPPRESSING BODY TEMPERATURE ELEVATION
A body temperature lowering agent, a body temperature elevation suppressor, a food composition for lowering body temperature, and a food composition for suppressing body temperature elevation containing at least one substance selected from the group consisting of orotic acid, a derivative thereof, and a salt of the orotic acid or the derivative as an active ingredient.
NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
DAICO MFG CO., LTD. (Japon)
Inventeur(s)
Kumada, Hiroaki
Kitamura, Naoyuki
Nakamura, Tetsuyuki
Ikeda, Takeshi
Abrégé
The purpose is to prevent the irradiation beam from leaking between the beam irradiation port of the radiation therapy device and the patient affected area that is the target of the emitted irradiation beam, a radiation shielding jig comprising a tare filled with shielding material particles; the tare is made of a resin fabric and has a hollow three-dimensional shape with a radiation pathway portion, the shielding material particles comprising a mixture of sintered particles having a predetermined particle diameter with radiation shielding performance and resin particles having a predetermined particle diameter.
This apparatus (1) comprises at least one intravascular device (10), (20) that is disposed in a blood vessel of an organism and that is equipped with at least one electrode (11), (12), (21), (22) for detecting or stimulating the activity of nerve tissue positioned outside the blood vessel nearby, the electrodes (11), (12), (21), (22) being provided on a wire member.
A61B 5/293 - Détection, mesure ou enregistrement de signaux bioélectriques ou biomagnétiques du corps ou de parties de celui-ci Électrodes bioélectriques à cet effet spécialement adaptées à des utilisations particulières pour l’électroencéphalographie [EEG] invasives
A61B 5/00 - Mesure servant à établir un diagnostic ; Identification des individus
A secondary battery of the present disclosure includes a positive electrode, an electrolyte layer, a negative electrode current collector, and metallic lithium as a negative electrode active material that is deposited between the electrolyte layer and the negative electrode current collector by charging, an intermediate layer is present between the electrolyte layer and the negative electrode current collector, and the intermediate layer contains hydrogen boride.
The present invention provides a method for producing natural polymer microspheres, the method including: adding a solution containing a natural polymer (e.g., an aqueous fibroin solution) to an organic solvent, the organic solvent having a surfactant dissolved therein, and homogenizing the resulting mixed solution to generate a natural polymer colloidal suspension; and adding the natural polymer colloidal suspension to an alcohol having 3 or more carbon atoms to form natural polymer microspheres.
NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
UNIVERSITY OF TSUKUBA (Japon)
Inventeur(s)
Nosato, Hirokazu
Kochi, Yuta
Sakanashi, Hidenori
Murakawa, Masahiro
Ikeda, Atsushi
Abrégé
An endoscopic diagnosis support method whereby an examined area and an unexamined area can be clearly discriminated. After a preparatory step of an observation canvas is performed in advance, a frame marking step, a key point calculation step, a preceding and following frame displacement amount calculation step, a preceding and following frame marking step are executed to thereby perform observation recording. In an image diagnosis support step IDS, support is performed such that the existence of a lesion is diagnosed in an organ on the basis of a plurality of position data marked with respect to a plurality of frames in the observation canvas data and an endoscopic image in the plural frames.
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicales; TIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p.ex. basé sur des systèmes experts médicaux
G06V 10/44 - Extraction de caractéristiques locales par analyse des parties du motif, p.ex. par détection d’arêtes, de contours, de boucles, d’angles, de barres ou d’intersections; Analyse de connectivité, p.ex. de composantes connectées
G06T 7/73 - Détermination de la position ou de l'orientation des objets ou des caméras utilisant des procédés basés sur les caractéristiques
A61B 1/05 - Instruments pour procéder à l'examen médical de l'intérieur des cavités ou des conduits du corps par inspection visuelle ou photographique, p.ex. endoscopes; Dispositions pour l'éclairage dans ces instruments combinés avec des dispositifs photographiques ou de télévision caractérisés par le fait que le capteur d'images, p.ex. l'appareil photographique, est placé dans la partie de l'extrémité distale
G16H 30/40 - TIC spécialement adaptées au maniement ou au traitement d’images médicales pour le traitement d’images médicales, p.ex. l’édition
G06V 10/764 - Dispositions pour la reconnaissance ou la compréhension d’images ou de vidéos utilisant la reconnaissance de formes ou l’apprentissage automatique utilisant la classification, p.ex. des objets vidéo
A61B 1/00 - Instruments pour procéder à l'examen médical de l'intérieur des cavités ou des conduits du corps par inspection visuelle ou photographique, p.ex. endoscopes; Dispositions pour l'éclairage dans ces instruments
7.
NON-TRANSITORY COMPUTER READABLE RECORDING MEDIUM, INFORMATION PROCESSING METHOD AND INFORMATION PROCESSING APPARATUS
A non-transitory computer-readable recording medium has stored therein a program that causes a computer to execute a process, the process including acquiring movie data including a plurality of consecutive frames calculating first likelihood of a class of the movie data by inputting the acquired movie data to a trained model, calculating an optical flow indicating movement of an area included in the movie data, based on the movie data generating occluded movie data by setting an occluded area in each of the frames included in the movie data, based on the optical flow, calculating second likelihood of a class of the occluded movie data by inputting the occluded movie data to the model identifying an area that affects identification of the class among areas in the movie data, based on the first likelihood and the second likelihood and displaying the identified area that affects identification of the class.
G06V 20/40 - RECONNAISSANCE OU COMPRÉHENSION D’IMAGES OU DE VIDÉOS Éléments spécifiques à la scène dans le contenu vidéo
G06V 10/774 - Dispositions pour la reconnaissance ou la compréhension d’images ou de vidéos utilisant la reconnaissance de formes ou l’apprentissage automatique utilisant l’intégration et la réduction de données, p.ex. analyse en composantes principales [PCA] ou analyse en composantes indépendantes [ ICA] ou cartes auto-organisatrices [SOM]; Séparation aveugle de source méthodes de Bootstrap, p.ex. "bagging” ou “boosting”
G06V 10/82 - Dispositions pour la reconnaissance ou la compréhension d’images ou de vidéos utilisant la reconnaissance de formes ou l’apprentissage automatique utilisant les réseaux neuronaux
8.
COPOLYMER CONTAINING POLY(ETHYLENE GLYCOL) AND POLY(L-AMINO ACID DERIVATIVE), MICROPARTICLES THEREOF AND USE THEREOF IN PHARMACEUTICAL COMPOSITION
An objective of the present invention is to provide a self-assembled polymer micelle-type ornithine donor, which has high bioavailability, low toxicity, and high therapeutic effectiveness, even when provided by oral administration. Another objective of the present invention is to provide a self-assembled polymer micelle-type ornithine donor which is effective in preventing or treating hepatic disorders. In order to achieve the above objectives, an acyl group is introduced into the primary amino group in the side chain of an ornithine unit in the poly(ornithine) segment of poly(ethylene glycol)-b-poly(ornithine), which spontaneously forms polymer micelles without polyion complex formation.
To stably support a user before and after posture transition between a standing position and a sitting position by suppressing forward and backward movement of a position of the center of gravity of a user without power supply with a simple configuration. A stable support mechanism includes a base, a support structure mounted on the base, the support structure being configured to be capable of translational movement along a first axis in a plane horizontal to the base, the support structure being configured to be capable of changing a posture between a first position and a second position in a plane perpendicular to the base, and a link having a fixed length, one end of the link being connected to the base, the other end of the link being connected to the support structure, the link being configured to guide the support structure in a direction along the first axis along with changing the posture of the support structure.
Biomarkers for detecting cognitive dysfunction diseases and methods for detecting cognitive dysfunction diseases using the biomarkers are provided. A method for detecting cognitive dysfunction diseases comprising measuring one or more biomarkers for detecting cognitive dysfunction diseases selected from the following (a), (b), and (c) in a biological sample simultaneously or separately: (a) a biomarker for detecting cognitive dysfunction diseases consisting of an intact protein of apolipoprotein A1 comprising the amino acid sequence represented by SEQ ID NO:1 or a partial peptide thereof; (b) a biomarker for detecting cognitive dysfunction diseases consisting of an intact protein of transthyretin comprising the amino acid sequence represented by SEQ ID NO:2 or a partial peptide thereof; and (c) a biomarker for detecting cognitive dysfunction diseases consisting of an intact protein of complement C3 comprising the amino acid sequence represented by SEQ ID NO:3 or a partial peptide thereof.
G01N 33/68 - Analyse chimique de matériau biologique, p.ex. de sang ou d'urine; Test par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligands; Test immunologique faisant intervenir des protéines, peptides ou amino-acides
C07K 14/47 - Peptides ayant plus de 20 amino-acides; Gastrines; Somatostatines; Mélanotropines; Leurs dérivés provenant d'humains provenant de vertébrés provenant de mammifères
11.
FEATURE AMOUNT SELECTION DEVICE, FEATURE AMOUNT SELECTION METHOD, AND PROGRAM
A feature amount selection device includes a feature amount data acquisition unit that acquires feature amount data including a set of values of a plurality of feature amounts for a sample, for each of a plurality of the samples, a principal component analysis unit that performs, on the feature amount data, principal component analysis in a sample space that is a collection of the plurality of feature amounts of a set of values for each of the plurality of the samples of the feature amounts, and a feature amount selection unit that selects a feature amount from among the plurality of the feature amounts based on a result of the principal component analysis performed by the principal component analysis unit.
A secure computation system comprising secure computation server apparatuses, each of which comprises: a discriminant share generation part that computes discriminant shares configured so that an index relating to an input corresponds to a specific value from shares representing the index relating to the input and possible combinations of index shares of an array; a combination configuration part that configures a combination of shares of an element in the array and the discriminant shares for all possible combinations of indices of the array; a shuffle part that shuffles the combinations; a reconstruction part that reconstructs the discriminant shares in the shuffled combinations; and a selection part that selects shares of an element in the array in the combinations where the reconstructed value is the specific value.
G06F 21/57 - Certification ou préservation de plates-formes informatiques fiables, p.ex. démarrages ou arrêts sécurisés, suivis de version, contrôles de logiciel système, mises à jour sécurisées ou évaluation de vulnérabilité
An image display device displays a stereoscopic image by using a parallax barrier method and includes a transmissive image display surface on which images of left-eye image data and right-eye image data are alternately displayed; an image forming unit including optical members having strip-shaped patterns with optical properties arranged on a surface located on a back surface side of the image display surface; and strip-shaped light sources arranged on an illumination arrangement surface, which is a surface located on a back surface side of the image forming unit, and configured to irradiate the image display surface with illumination light. A slit area of the parallax barrier method is formed by an image obtained by forming an image of the illumination light from the strip-shaped light sources on the back surface side of the image display surface by using the optical members of the image forming unit.
H04N 13/312 - Reproducteurs d’images pour visionnement sans avoir recours à des lunettes spéciales, c. à d. utilisant des affichages autostéréoscopiques utilisant des barrières de parallaxe les barrières de parallaxe étant situées derrière l’affichage, p.ex. entre la source de rétroéclairage et le modulateur spatial de lumière [MSL]
H04N 13/305 - Reproducteurs d’images pour visionnement sans avoir recours à des lunettes spéciales, c. à d. utilisant des affichages autostéréoscopiques utilisant des lentilles lenticulaires, p.ex. dispositions de lentilles cylindriques
H04N 13/315 - Reproducteurs d’images pour visionnement sans avoir recours à des lunettes spéciales, c. à d. utilisant des affichages autostéréoscopiques utilisant des barrières de parallaxe les barrières de parallaxe variant dans le temps
14.
NERVE FASCICLE AND METHOD OF PRODUCING NERVE FASCICLE
[Object] Provided is a method of producing a nerve fascicle including efficiently extending axons of neural cells.
[Object] Provided is a method of producing a nerve fascicle including efficiently extending axons of neural cells.
[Solution] Neural cells are cultivated in the presence of feeder cells including at least one type of cells selected from the group consisting of vascular component cells, perivascular cells, and oligodendrocytes.
A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
C12N 5/071 - Cellules ou tissus de vertébrés, p.ex. cellules humaines ou tissus humains
An imaging lighting instrument for an operation is disposed in a space between an operator's head and a patient, thereby configuring a multi-viewpoint video capturing device for a surgical operation in which blocking of a light by the operator's head or body and appearance of the head in a video are avoided. The imaging lighting instrument includes a plurality of cameras and a plurality of lights attached to a hollow ring-shaped or arc-shaped housing made of a wire member of a finite length, which is devised so as not to interfere with the visual field or work of the operator. Furthermore, the multi-viewpoint video capturing device is configured to have a function of estimating the context of the plurality of cameras and make it possible to perform operation support/recording of a direct-view surgical operation by using a multi-viewpoint video by adding a video information processing function for selecting a camera video in which an operators' hand or surgical instruments less appear in an image.
A61B 90/00 - Instruments, outillage ou accessoires spécialement adaptés à la chirurgie ou au diagnostic non couverts par l'un des groupes , p.ex. pour le traitement de la luxation ou pour la protection de bords de blessures
A rocking device includes: a seat which supports a body of a user; a motor which rotates a rotation shaft in a first rotation direction and in a second rotation direction that is a rotation direction opposite to the first rotation direction, and thereby supplies motive power for rocking the seat via a gear attached to the rotation shaft; and a controller which controls rocking of the seat via the motor. The seat is configured to make a first motion of moving in a first movement direction, in accordance with rotation of the rotation shaft in the first rotation direction, and make a second motion of moving in a second movement direction, in accordance with rotation of the rotation shaft in the second rotation direction. The controller is configured to control rocking of the seat such that a prescribed stopped period is provided between the first motion and second motion.
An information processing apparatus acquires an image; generates a shielding image in which a part of an area included in an area of the acquired image has been shielded; calculates, by inputting the image to a first model that has been trained, first likelihood of the target object included in the image; calculates, by inputting the shielding image to a second model that calculates an approximation value of likelihood of the target object included in the image when the image is input, second likelihood corresponding to the approximation value of the likelihood of the target object included in the shielding image; specifies, based on the first likelihood and the second likelihood, an area that affects discrimination of the class and that is included in the area of the image; and displays the specified area that affects discrimination of the class.
G06V 10/36 - Utilisation d’un opérateur local, c. à d. des moyens pour opérer sur des points d’image situés dans la proximité d’un point donné; Opérations de filtrage locales non linéaires, p.ex. filtrage médian
G06V 10/764 - Dispositions pour la reconnaissance ou la compréhension d’images ou de vidéos utilisant la reconnaissance de formes ou l’apprentissage automatique utilisant la classification, p.ex. des objets vidéo
A stage of sleep is easily estimated. A sleep estimation device includes a first acquisition unit configured to acquire blood flow data, a generation unit configured to generate a frequency spectrum of the blood flow data by performing frequency analysis processing on the blood flow data, and a first determination unit configured to determine a stage of sleep of a subject based on the frequency spectrum.
A paramylon-based resin having a weight-average molecular weight of paramylon in a range of 70000 to 140000, and formed by substituting hydrogen atoms of hydroxy groups of a paramylon with a long-chain component being a linear saturated aliphatic acyl group having 14 or more carbon atoms and a short-chain component being an acyl group (acetyl group or/and propionyl group) having 2 or 3 carbon atoms, wherein a degree of substitution with the long-chain component (DSLo) and a degree of substitution with the short-chain component (DSSh) satisfy the following conditional expressions (1) and (2), Izod impact strength is 5.0 kJ/m2 or more, and an MFR (melt flow rate at 210° C. and under a load of 5 kg) is 2 g/10 min or more. To provide a paramylon-based resin excellent in mechanical characteristics and thermoplasticity. 2.2≤DSLo+DSSh≤2.8 (1) 5≤DSSh/DSLo≤25 (2)
A first estimation unit (331) estimates command information per first unit of time using a first trained model (321). A second estimation unit (332) estimates, using a second trained model (322), the command information per second unit of time shorter than the first unit of time, from information corresponding to the command information derived by the first trained model (321). An operation control unit (333) operates a control target device (10B) using the command information estimated by the second estimation unit (332).
An object is to elucidate the immune response mechanism of IL-17-producing cells which causes a pathological condition such as psoriasis, and to provide an immune response suppressant for suppressing the immune response of IL-17-producing cells, a medicament for treating or preventing a disease or a pathological condition involving the immune response of an IL-17-producing cell, a method for inducing immune response in γδT cells, and a method for evaluating a medicament (candidate substance) and a method for producing IL-17 by use of the method. The present invention provides an immune response suppressant for an IL-17-producing cell, including a substance that inhibits the binding of CD96 to at least one protein selected from CD155 and CD111, a medicament including the immune response suppressant for an IL-17-producing cell, a method having a step (A) of culturing at least one of a γδT cell and a CD4-positive T cell together with IL-23, an anti-CD3 antibody capable of stimulating a TCR/CD3 complex and an anti-CD96 antibody capable of stimulating CD96, and a method for evaluating a medicament (candidate substance) and a method for producing IL-17, including a method having the step (A).
C07K 16/28 - Immunoglobulines, p.ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des récepteurs, des antigènes de surface cellulaire ou des déterminants de surface cellulaire
G01N 33/50 - Analyse chimique de matériau biologique, p.ex. de sang ou d'urine; Test par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligands; Test immunologique
C12P 21/02 - Préparation de peptides ou de protéines comportant une séquence connue de plusieurs amino-acides, p.ex. glutathion
A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p.ex. agents antirhumatismaux; Médicaments anti-inflammatoires non stéroïdiens [AINS]
An image generation device includes a tomographic image acquisition unit configured to acquire an OCTA tomographic image that captures a distribution of a blood flow of an object, a light attenuation acquisition unit configured to acquire a light attenuation of measurement light emitted to the object in a direction in which the tomographic image is layered, and an image generation unit configured to generate a light attenuation-blood flow distribution chart indicating a distribution of the light attenuation based on the acquired OCTA tomographic image and the light attenuation.
A61B 3/12 - Appareils pour l'examen optique des yeux; Appareils pour l'examen clinique des yeux du type à mesure objective, c. à d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient pour examiner le fond de l'œil, p.ex. ophtalmoscopes
A61B 3/00 - Appareils pour l'examen optique des yeux; Appareils pour l'examen clinique des yeux
A61B 3/10 - Appareils pour l'examen optique des yeux; Appareils pour l'examen clinique des yeux du type à mesure objective, c. à d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient
23.
DISEASE-CONDITION ASSESSMENT DEVICE, DISEASE-CONDITION ASSESSMENT METHOD, PROGRAM FOR DISEASE-CONDITION ASSESSMENT DEVICE, AND DISEASE-CONDITION ASSESSMENT SYSTEM
NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
UNIVERSITY OF TSUKUBA (Japon)
YAZAKI CORPORATION (Japon)
SUBARU CORPORATION (Japon)
MITSUBISHI ELECTRIC CORPORATION (Japon)
Inventeur(s)
Komine, Hidehiko
Kitazaki, Satoshi
Akakatsu, Motoyuki
Ishii, Kei
Tsurushima, Hideo
Shino, Motoki
Abrégé
Provided are a disease-condition assessment device for being capable of assessing an epileptic condition of a subject, a disease-condition assessment method, a program for disease-condition assessment device, and a disease-condition assessment system. The gaze data indicating a subject's gazing point measured when the subject is driving a vehicle is acquired, the driving-characteristic data indicating driving characteristics of the subject for the vehicle is acquired), and the epileptic condition of the subject is assessed depending on the relationship between the gaze data and the driving-characteristic data.
B60W 40/08 - Calcul ou estimation des paramètres de fonctionnement pour les systèmes d'aide à la conduite de véhicules routiers qui ne sont pas liés à la commande d'un sous-ensemble particulier liés aux conducteurs ou aux passagers
A61B 5/00 - Mesure servant à établir un diagnostic ; Identification des individus
G06V 20/59 - Contexte ou environnement de l’image à l’intérieur d’un véhicule, p.ex. concernant l’occupation des sièges, l’état du conducteur ou les conditions de l’éclairage intérieur
24.
PARAMYLON-BASED RESIN, MOLDING MATERIAL, MOLDED BODY, AND PRODUCTION METHOD FOR PARAMYLON-BASED RESIN
A paramylon-based resin excellent in mechanical characteristics and thermoplasticity is provided. The present embodiment provides a paramylon-based resin in which hydrogen atoms of hydroxy groups of paramylon are substituted by linear saturated aliphatic acyl group having 14 or more carbon atoms as a long chain component and/or acyl group having 2 or 3 carbon atoms (acetyl group or/and propionyl group) as a short chain component, wherein the paramylon has a weight average molecular weight in the range of more than 140000 to 220000 and a molecular weight distribution (weight average molecular weight/number average molecular weight) of 6.5 or less, a protein content of the paramylon is 0.22% by mass to 5.0% by mass, and a degree of substitution (DSLo) by the long chain component and a degree of substitution (DSSh) by the short chain component satisfy the following expressions (S1), (L1) and (T1); 1.7≤DSSh≤2.8 (S1), 0≤DSLo≤0.4 (L1), 2.1≤DSLo+DSSh≤2.8 (T1).
A model learning unit determines a model parameter for calculating an estimated value for each of a plurality of training sets, each including a measurement signal and at least one type of predetermined characteristic value indicating characteristics of the measurement signal as a target value, to minimize a difference between the estimated value calculated for the measurement signal using a predetermined mathematical model and the target value is minimized, determines characteristic value sets, each being a set of a plurality of types of characteristic values indicating characteristics of the measurement signal including the target value, with which, for each target value, the target value is common to a plurality of characteristic value sets, and generates, for each of the characteristic value sets, each of the plurality of training sets including the target value and a measurement signal having characteristics indicated by the plurality of types of characteristic values.
The invention provides an HIF-1 activator for treatment, prevention, alleviation, improvement or recovery from diseases or symptoms associated with reduced HIF-1 activity, as well as a pharmaceutical composition, cosmetic and food composition comprising the activator. Provided is an HIF-1 activator comprising olive leaf extract. Also provided is an HIF-1 activator which is for maintaining the undifferentiated state of stem cells via HIF-1 activation and/or improving dysdifferentiation of stem cells.
A61K 36/63 - Oleaceae (famille de l'olive), p.ex. jasmin, lilas ou frêne
A61K 31/7048 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'oxygène comme hétéro-atome d'un cycle, p.ex. leucoglucosane, hespéridine, érythromycine, nystatine
A mobility support device capable of stably climbing a step without impairing mobility on flat ground is provided. The mobility support device includes a front wheel, a rear wheel, a drive wheel disposed between the front wheel and the rear wheel, a first link coupled to the front wheel, a second link connecting the drive wheel and the rear wheel, a rotation joint coupling the first link and the second link at a first position, and a first elastic member coupling the first link and the second link at a second position different from the first position.
A61G 5/06 - Fauteuils ou moyens de transport personnels spécialement adaptés pour des personnes handicapées, p.ex. fauteuils roulants avec dispositions pour franchir les obstacles, p.ex. pour monter les escaliers
A61G 5/10 - Fauteuils ou moyens de transport personnels spécialement adaptés pour des personnes handicapées, p.ex. fauteuils roulants - Parties constitutives, détails ou accessoires
28.
TRAINED MODEL GENERATION PROGRAM, IMAGE GENERATION PROGRAM, TRAINED MODEL GENERATION DEVICE, IMAGE GENERATION DEVICE, TRAINED MODEL GENERATION METHOD, AND IMAGE GENERATION METHOD
A trained model generation program causes a computer to implement a learning execution function of inputting first input image data representing a first input image generated by a first reconstruction method using compressed sensing and second input image data representing a second input image generated by a second reconstruction method different from the first reconstruction method to a machine learning device to execute machine learning, the second reconstruction method being an analytical reconstruction method, and causing the machine learning device to generate a trained model, and a trained model acquisition function of acquiring trained model data indicating the trained model. Then, input image data representing an input image is input to the trained model to generate a reconstructed image with improved image quality.
G06V 10/82 - Dispositions pour la reconnaissance ou la compréhension d’images ou de vidéos utilisant la reconnaissance de formes ou l’apprentissage automatique utilisant les réseaux neuronaux
29.
DIAGNOSTIC IMAGING SUPPORT DEVICE, DIAGNOSTIC IMAGING SUPPORT SYSTEM, AND DIAGNOSTIC IMAGING SUPPORT METHOD
NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM (Japon)
UNIVERSITY OF TSUKUBA (Japon)
Inventeur(s)
Mori, Kensaku
Oda, Masahiro
Oshika, Tetsuro
Ueno, Yuta
Yamaguchi, Takefumi
Fukuoka, Hideki
Abrégé
A diagnostic imaging support device includes: a learning unit that calculates a feature quantity about each of infectiousness condition and non-infectiousness condition for determining a condition in a determination image of an anterior eye through machine learning on the basis of a learning image of an anterior eye and information about a condition in the learning image.
H04N 7/173 - Systèmes à secret analogiques; Systèmes à abonnement analogiques à deux voies, p.ex. l'abonné envoyant un signal de sélection du programme
H04N 5/85 - Enregistrement du signal de télévision utilisant l'enregistrement optique sur des disques ou sur des tambours
30.
MUTANT KLF PROTEIN, AND METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELLS
There is provided a mutant KLF protein that can induce reprogramming of a somatic cell at a higher efficiency than a KLF protein having a natural amino acid sequence. There is also provided a method for efficiently producing an iPS cell by using the mutant KLF protein. There is provided a mutant KLF protein having an amino acid substitution, or a peptide fragment thereof containing the amino acid substitution.
C12N 15/85 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules animales
C07K 14/47 - Peptides ayant plus de 20 amino-acides; Gastrines; Somatostatines; Mélanotropines; Leurs dérivés provenant d'humains provenant de vertébrés provenant de mammifères
31.
HYDROGEN STORAGE AND RELEASE MATERIAL AND METHOD OF PRODUCING SAME
The present invention provides a hydrogen storage and release material including a two-dimensional hydrogen boride-containing sheet including a two-dimensional network containing n(HxBy) (n≥4, 0.001≤x/y≤0.999) having a molar ratio of boron to hydrogen from 1:0.999 to 1:0.001, the molar ratio being determined by thermal desorption spectroscopy, and mass measurement before and after a temperature rise, wherein the hydrogen storage and release material has: peaks derived from B1s of boron at 187.5±1.0 eV and 191.2±1.0 eV to 193±1.0 eV in X-ray photoelectron spectroscopy, and a peak derived from a B—H stretching vibration at from 2400 cm−1 to 2600 cm−1 and also a peak derived from a B—H—B stretching vibration at from 1200 cm−1 to 1800 cm−1 in infrared spectroscopy.
C01B 3/00 - Hydrogène; Mélanges gazeux contenant de l'hydrogène; Séparation de l'hydrogène à partir de mélanges en contenant; Purification de l'hydrogène
C01B 6/10 - Monoborane; Diborane; Leurs complexes d'addition
32.
SIGNAL PROCESSING DEVICE, SIGNAL PROCESSING METHOD, AND SIGNAL PROCESSING PROGRAM
A phase gradient calculation unit calculates a phase gradient on a plane intersecting an irradiation direction of light corresponding to an optical coherence tomography signal indicating a state of a sample for each of sample points arranged on the plane. A bulk phase error calculation unit integrates, for each of plurality of paths from an origin that is a sample point where a bulk phase error is determined to a destination that is a sample point where the bulk phase error is not determined, the phase gradient for each of the sample points along each of the plurality of corresponding paths to calculate a path specific phase error at the destination, and combines the path specific phase errors among the plurality of corresponding paths to determine the bulk phase error at the destination.
Provided is an evaluation method for a biological tissue that enables dynamics of the biological tissue to be quantitatively evaluated. In the evaluation method of the present embodiment, an optical coherence tomography (OCT) signal indicating a state of a biological tissue provided as a sample is acquired, a signal value based on the OCT signal is acquired at an observation point in the sample, and a temporal variation characteristic value indicating a temporal variation characteristic of the signal value within a predetermined period is calculated. The present embodiment can also be implemented with an evaluation device or even with a program.
The present invention relates to: an activity modulator which is a means for modulating the activity of CD300b-dependent phagocytosis; and medicine for the treatment or prevention of a disease or condition in which the activity is involved. The activity modulator comprises a CD300a-binding substance and modulates CD300b-dependent phagocytosis signals in a macrophage.
C07K 16/28 - Immunoglobulines, p.ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des récepteurs, des antigènes de surface cellulaire ou des déterminants de surface cellulaire
A61P 9/10 - Médicaments pour le traitement des troubles du système cardiovasculaire des maladies ischémiques ou athéroscléreuses, p.ex. médicaments antiangineux, vasodilatateurs coronariens, médicaments pour le traitement de l'infarctus du myocarde, de la rétinopathie, de l'insuffisance cérébro-vasculaire, de l'artériosclérose rénal
A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
A carbon nanotube-resin composite includes: a carbon nanotube assembled wire including a plurality of carbon nanotubes; and a resin, wherein in the carbon nanotube assembled wire, the carbon nanotubes are oriented at a degree of orientation of 0.9 or more and 1 or less.
D02G 3/02 - Filés ou fils caractérisés par la matière ou par les matières dont ils sont composés
D01F 9/127 - Filaments de carbone; Appareils spécialement adaptés à leur fabrication par décomposition thermique de gaz ou vapeurs d'hydrocarbures
D02G 3/40 - Filés dans lesquels les fibres sont réunies par des adhésifs; Filés ou fils imprégnés
H01B 1/24 - Matériau conducteur dispersé dans un matériau organique non conducteur le matériau conducteur comportant des compositions à base de carbone-silicium, du carbone ou du silicium
H01B 13/00 - Appareils ou procédés spécialement adaptés à la fabrication de conducteurs ou câbles
36.
HYDROPHILIC-HYDROPHOBIC COPOLYMER CARRYING SHORT CHAIN FATTY ACID ESTER
[Object]
[Object]
To provide a derivative of a short chain fatty acid that can exhibit physiological functions inherent in the short chain fatty acid.
[Object]
To provide a derivative of a short chain fatty acid that can exhibit physiological functions inherent in the short chain fatty acid.
[Solution]
[Object]
To provide a derivative of a short chain fatty acid that can exhibit physiological functions inherent in the short chain fatty acid.
[Solution]
Provided is a block or graft copolymer including a hydrophobic segment of a repeat unit containing a short chain fatty acid ester that is hydrolyzable by esterase in vivo and a hydrophilic segment including a poly(ethylene glycol) chain. These copolymers are effective in the treatment or therapeutic treatment of various diseases or disorders, including cancer.
C08F 293/00 - Composés macromoléculaires obtenus par polymérisation sur une macromolécule contenant des groupes capables d'amorcer la formation de nouvelles chaînes polymères rattachées exclusivement à une ou aux deux extrémités de la macromolécule de départ
C08G 65/26 - Composés macromoléculaires obtenus par des réactions créant une liaison éther dans la chaîne principale de la macromolécule à partir d'éthers cycliques par ouverture d'un hétérocycle à partir d'éthers cycliques et d'autres composés
C08G 65/334 - Polymères modifiés par post-traitement chimique avec des composés organiques contenant du soufre
NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
DAICO MFG CO., LTD. (Japon)
Inventeur(s)
Kumada, Hiroaki
Kitamura, Naoyuki
Nakamura, Tetsuyuki
Ikeda, Takeshi
Abrégé
As a sintered body for a radiation shielding material, which can effectively shield mainly low-energy-level neutrons, that is, thermal neutrons and lower, slow neutrons, and has excellent physical properties such as bending strength and Vickers hardness, leading to high machining strength, a sintered body for a radiation shielding material comprising LiF ranging between 99 wt. % to 5 wt. %, and one or more fluorides selected from among MgF2, CaF2, AlF3, KF, NaF, and/or YF3 ranging between 1 wt. % to 95 wt. %, having physical properties of a relative density of 92% or more, a bending strength of 50 MPa or more, and a Vickers hardness of 100 or more, is provided.
G21F 1/08 - Métaux; Alliages; Cermets, c. à d. mélanges frittés de céramiques et métaux
C04B 35/553 - Produits céramiques mis en forme, caractérisés par leur composition; Compositions céramiques; Traitement de poudres de composés inorganiques préalablement à la fabrication de produits céramiques à base de non oxydes à base de fluorures
C04B 35/626 - Préparation ou traitement des poudres individuellement ou par fournées
A method for inducing a hibernation-like state and a device for the same is described. The method is a chemical and physical method for reducing, in a subject, a theoretical set-point temperature of a body temperature and/or a feedback gain of heat production, or for inducing a hibernation-like state in the subject, the method including applying an excitatory stimulus to pyroglutamylated RFamide peptide (QRFP)-producing neurons. A device used to implement the method is also described.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p.ex. stimulateurs cardiaques
A61N 1/05 - Electrodes à implanter ou à introduire dans le corps, p.ex. électrode cardiaque
A61M 21/02 - Autres dispositifs ou méthodes pour amener un changement dans l'état de conscience; Dispositifs pour provoquer ou arrêter le sommeil par des moyens mécaniques, optiques ou acoustiques, p.ex. pour mettre en état d'hypnose pour provoquer le sommeil ou la relaxation, p.ex. par stimulation directe des nerfs, par hypnose ou par analgésie
G01N 33/50 - Analyse chimique de matériau biologique, p.ex. de sang ou d'urine; Test par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligands; Test immunologique
A carbon nanotube assembled wire includes a plurality of carbon nanotubes, wherein in a Raman spectrum of the carbon nanotube assembled wire, a ratio IB/IA of an integrated intensity IA in a range of a Raman shift of 120 cm−1 or more and 210 cm−1 or less and an integrated intensity IB in a range of a Raman shift of more than 210 cm−1 and 280 cm−1 or less is 0.1 or more.
The present application provides: a fruit-bearing plant exhibiting parthenocarpy or a potion thereof including a mutation in a Solyc10g038170 gene or ortholog thereof, the mutation causing deficiency or reduction in expression of a protein encoded by the Solyc10g038170 gene or ortholog thereof; a method for producing a parthenocarpic fruit-bearing plant or a potion thereof; and a method for selecting a parthenocarpic fruit-bearing plant or a potion thereof.
C12N 15/82 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules végétales
C12Q 1/6895 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p.ex. amorces ou sondes pour la détection ou l’identification d’organismes pour les plantes, les champignons ou les algues
C07K 14/415 - Peptides ayant plus de 20 amino-acides; Gastrines; Somatostatines; Mélanotropines; Leurs dérivés provenant de végétaux
NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
UNIVERSITY OF TSUKUBA (Japon)
Inventeur(s)
Iwata, Yasushi
Tomita, Kanako
Suzuki, Iwane
Morioka, Ryo
Yang, Tianjing
Abrégé
An artificial gene has a 15N abundance exceeding a natural abundance in bases of at least a portion of DNA. A method for mutating a gene includes a first step of producing a state in which 15N is unevenly distributed into a prescribed DNA in a living cell; and a second step of irradiation with a proton beam at an energy at which the 15N produces a resonant nuclear reaction.
It is possible to quickly and efficiently support a user with a limited lower limb motor function in a posture transition with a simplified configuration. A support mechanism that supports a posture transition includes a first link that does not change a posture, a second link that is rotatably coupled to the first link, and an actuator configured to rotate the second link with respect to the first link, in which, when a load on a connection part of the second link and the first link changes due to a change in an upper body posture of a user, based on a relative positional relationship between an ankle joint and a knee joint of the user in a direction orthogonal to a vertical direction in a sagittal plane of the user, the actuator drives the second link while changing a support moment on the user according to a relative positional relationship between the knee joint and an upper body centroid of the user, or a knee joint angle.
A method of processing ophthalmic data of some embodiment examples includes preparing a data set acquired by applying optical scanning of a two-dimensional pattern to a subject's eye. The two-dimensional pattern of the optical scanning includes a series of cycles that intersects each other. The method further includes generating position history data based on the data set. The position history data represents a temporal change in a position of the subject's eye.
A61B 3/10 - Appareils pour l'examen optique des yeux; Appareils pour l'examen clinique des yeux du type à mesure objective, c. à d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient
A61B 3/14 - Dispositions spécialement adaptées à la photographie de l'œil
A61B 3/113 - Appareils pour l'examen optique des yeux; Appareils pour l'examen clinique des yeux du type à mesure objective, c. à d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient pour déterminer ou enregistrer le mouvement de l'œil
A61B 3/00 - Appareils pour l'examen optique des yeux; Appareils pour l'examen clinique des yeux
An inhibitor of cell death induced by transient protein expression in a plant, the inhibitor including, as an active ingredient, ascorbic acid or a derivative thereof, a salt thereof, or a solvate thereof, can advantageously inhibit cell death induced by transient protein expression in a plant.
A01N 43/08 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des composés hétérocycliques comportant des cycles avec un ou plusieurs atomes d'oxygène ou de soufre comme uniques hétéro-atomes du cycle avec un hétéro-atome des cycles à cinq chaînons avec l'oxygène comme hétéro-atome du cycle
C12N 15/82 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules végétales
A01P 21/00 - Régulateurs de croissance des végétaux
National Institute of Advanced Industrial Science and Technology (Japon)
ZEON CORPORATION (Japon)
Inventeur(s)
Isoda, Hiroko
Sasaki, Kazunori
Sato, Kazuhiko
Asakawa, Masumi
Tominaga, Kenichi
Fujisawa, Hiroshi
Koshiyama, Masami
Abrégé
Provided is a neuronal function modulating agent effective for neuronal cell protection and exerts a neuronal function modulating effect through neuronal cell protection. The disclosed neuronal function modulating agent comprises malvidin-3,5-diglucoside as an active ingredient, the disclosed pharmaceutical composition comprises the neuronal function modulating agent, and the disclosed food composition comprises the neuronal function modulating agent.
A61K 31/7048 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'oxygène comme hétéro-atome d'un cycle, p.ex. leucoglucosane, hespéridine, érythromycine, nystatine
A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
A61K 36/87 - Vitaceae ou Ampelidaceae (famille de la vigne ou du raisin), p.ex. raisin, vitis rotumdifolia ou vigne vierge
A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés
A23L 33/00 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement
NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
UNIVERSITY OF TSUKUBA (Japon)
Inventeur(s)
Tateno, Hiroaki
Oda, Tatsuya
Shimomura, Osamu
Abrégé
The present invention relates to a method for analyzing a biological sample obtained from a subject, comprising analyzing components contained in a biological sample by an assay using a first molecule selected from the group consisting of a molecule binding to a sugar chain bindable with BC2LCN, a molecule binding to SerpinA3, and a molecule binding to Gal3BP, and a second molecule that is BC2LCN.
A compression apparatus performs processing of registering a symbol, which is input, in a predetermined entry among a plurality of entries in a case where the symbol is not registered in a first table having the plurality of entries and outputting the symbol and index data indicating non-compression, processing of outputting index data indicating compression and positional information indicating a position of the entry having the symbol registered therein and having a size smaller than a size of the symbol in a case where the symbol has been registered in the table, and processing of changing the size of the positional information depending on usage conditions of the plurality of entries.
H03M 7/40 - Conversion en, ou à partir de codes de longueur variable, p.ex. code Shannon-Fano, code Huffman, code Morse
H03M 7/42 - Conversion en, ou à partir de codes de longueur variable, p.ex. code Shannon-Fano, code Huffman, code Morse utilisant une table pour le procédé de codage ou de décodage, p.ex. utilisant une mémoire morte
H03M 7/30 - Compression; Expansion; Elimination de données inutiles, p.ex. réduction de redondance
H03M 7/00 - Conversion d'un code, dans lequel l'information est représentée par une séquence donnée ou par un nombre de chiffres, en un code dans lequel la même information est représentée par une séquence ou par un nombre de chiffres différents
National Institute of Advanced Industrial Science and Technology (Japon)
ZEON CORPORATION (Japon)
Inventeur(s)
Isoda, Hiroko
Sasaki, Kazunori
Sato, Kazuhiko
Asakawa, Masumi
Tominaga, Kenichi
Fujisawa, Hiroshi
Koshiyama, Masami
Abrégé
Provided is a grape pericarp extract that exhibits neuronal function modulating effects. The grape pericarp extract comprises 15 mg/g or more of malvidin-3,5-diglucoside in dry mass.
A61K 36/87 - Vitaceae ou Ampelidaceae (famille de la vigne ou du raisin), p.ex. raisin, vitis rotumdifolia ou vigne vierge
A61K 31/7048 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'oxygène comme hétéro-atome d'un cycle, p.ex. leucoglucosane, hespéridine, érythromycine, nystatine
C12G 3/055 - Préparation d'autres boissons alcoolisées par mélange, p.ex. pour la préparation de liqueurs avec des ingrédients améliorant la santé, p.ex. des flavonoïdes, des flavones, des polyphénols ou des polysaccharides extraits de plantes
49.
CELL LAYER PERMEATION PROMOTER. COMPOSITION FOR FACILITATING DRUG ABSORPTION. AND PHARMACEUTICAL COMPOSITION
Tokyo University of Pharmacy and Life Sciences (Japon)
Inventeur(s)
Usui, Takeo
Nagumo, Yoko
Mukaiyama, Minagi
Hayashi, Yoshio
Taniguchi, Atsuhiko
Uchiyama, Chihiro
Abrégé
There is provided technology for promoting permeation of a substance into a cell layer. Provided is a cell layer permeation promoter comprising a compound represented by general formula (1). Also provided is a composition for facilitating drug absorption that contains the cell layer permeation promoter, said composition being for facilitating absorption of a drug into a living body. Also provided is a pharmaceutical composition that contains the cell layer permeation promoter and furthermore contains a drug to be absorbed into a living body.
There is provided technology for promoting permeation of a substance into a cell layer. Provided is a cell layer permeation promoter comprising a compound represented by general formula (1). Also provided is a composition for facilitating drug absorption that contains the cell layer permeation promoter, said composition being for facilitating absorption of a drug into a living body. Also provided is a pharmaceutical composition that contains the cell layer permeation promoter and furthermore contains a drug to be absorbed into a living body.
The present disclosure relates to a neural cell population, a neural cell-containing preparation, and a method for producing the population and preparation. More particularly, the present invention relates to a neural cell population derived from intraoral mesenchymal cells, wherein a proportion of normal diploid cells is 80% or more, a preparation containing the neural cell population, and a method for producing the population and the preparation.
National Institute of Advanced Industrial Science and Technology (Japon)
University of Tsukuba (Japon)
Nihon Parkerizing Co., Ltd. (Japon)
Inventeur(s)
Ohno, Tadao
Yasunaga, Mayu
Ito, Atsuo
Sogo, Yu
Kobayashi, Fumiko
Abrégé
A medical instrument in which an inorganic salt solid such as apatite into which a peptide hormone or the like is embedded is placed so that a metal or the like is coated therewith, in which the inorganic salt solid is provided by controlled delay co-precipitation or the like in an unstable supersaturated calcium phosphate solution, and the medical instrument is exposed to ionizing radiation at a dose sufficient for sterilization.
A61L 27/42 - Matériaux composites, c. à d. en couches ou contenant un matériau dispersé dans une matrice constituée d'un matériau analogue ou différent comportant une matrice inorganique
Provided are a skin disease analysis program, a skin disease analysis method, a skin disease analyzer, and a skin disease analysis system, which can analyze skin disease more accurately. The program according to the present invention is executed by a computer to execute a second step of predicting a kind of skin tumor for an image to be analyzed of skin tumor by a first-learned model that has machine learned from images of affected parts of various skin diseases in advance, and either one or both of a first step and a third step, in which the first step determines whether or not the image to be analyzed is an image of skin tumor by a skin disease determination engine, prior to the second step, and in a case where the determination result of the second step has been one kind of skin tumors that are easily mistaken for each other, the third step re-predicts the kind of skin tumor for the image to be analyzed by a second-learned model that has machine learned from images of affected parts of specific skin diseases including the skin tumors that are easily mistaken for each other.
The present invention provides a composition and method for treating an allergic disease. The composition comprises a ligand for asialoglycoprotein receptor 1 (Asgr1). The allergic disease may be atopic dermatitis, allergic rhinitis, urticaria, allergic asthma, allergic conjunctivitis, allergic gastrointestinal inflammation, or anaphylactic shock. The allergic disease may be caused by house dust mites. The present invention also provides a method for determining if a test compound activates human Asgr1.
A method for manufacturing a carbon nanotube includes: a mist generating step of generating a mist including a catalyst particle and a liquid carbon source; and a growing step of growing a carbon nanotube from the catalyst particle by heating the mist.
A reducing material including a two-dimensional hydrogen boride-containing sheet having a two-dimensional network composed of (BH)n (n≥4).
A reducing material including a two-dimensional hydrogen boride-containing sheet having a two-dimensional network composed of (BH)n (n≥4).
A composite including a two-dimensional hydrogen boride-containing sheet having a two-dimensional network composed of (BH)n (n≥4) and a metal nanoparticle.
A reducing material including a two-dimensional hydrogen boride-containing sheet having a two-dimensional network composed of (BH)n (n≥4).
A composite including a two-dimensional hydrogen boride-containing sheet having a two-dimensional network composed of (BH)n (n≥4) and a metal nanoparticle.
A reduction method including: a step of dispersing the reducing material according to any one of Claims 1 to 5 in an organic solvent to prepare a dispersion liquid containing the reducing material; and a step of reducing a metal ion having a redox potential which is given as a standard electrode potential of −0.26 V/SHE or higher by mixing the dispersion liquid with the metal ion.
KNEE JOINT ORTHOTIC DEVICE MANUFACTURING APPARATUS AND KNEE JOINT ORTHOTIC DEVICE MANUFACTURING METHOD, AND KNEE JOINT TREATMENT SUPPORT APPARATUS AND KNEE JOINT TREATMENT SUPPORT METHOD
Noninvasive natural healing in daily life or regenerative cell treatment can be promoted. A knee joint model is constructed by three-dimensionally analyzing measurement data obtained by measuring an outline shape and internal space shape of a knee joint part of a subject; a transition state towards an orthotic direction for a symptom improvement of the knee joint part is simulated continuously or stepwisely with reference to the knee joint model; and an exoskeleton mold capable of continuously or stepwisely finely adjusting the knee joint part towards the orthotic direction is designed based on the transition state.
A61F 5/01 - Dispositifs orthopédiques, p.ex. dispositifs pour immobiliser ou pour exercer des pressions de façon durable pour le traitement des os fracturés ou déformés, tels que éclisses, plâtres orthopédiques ou attelles
A61H 3/00 - Appareils pour aider des personnes handicapées à marcher
G06F 30/23 - Optimisation, vérification ou simulation de l’objet conçu utilisant les méthodes des éléments finis [MEF] ou les méthodes à différences finies [MDF]
B29C 33/38 - Moules ou noyaux; Leurs détails ou accessoires caractérisés par la matière ou le procédé de fabrication
A61B 5/107 - Mesure de dimensions corporelles, p.ex. la taille du corps entier ou de parties de celui-ci
A61H 1/02 - Appareils d'exercice extenseurs ou de ployage
Incorporation of L-DOPA into a carrier in a form of a block copolymer (PEG-b-poly(3,4-hydroxy-protected L-DOPA)) significantly improves the retention of the agent in the blood, thus mitigating a shortcoming associated with L-DOPA in treating Parkinson's disease.
A61K 47/60 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p.ex. les supports ou les additifs inertes; Agents de ciblage ou de modification chimiquement liés à l’ingrédient actif l’ingrédient non actif étant chimiquement lié à l’ingrédient actif, p.ex. conjugués polymère-médicament l’ingrédient non actif étant un agent de modification l’agent de modification étant un composé organique macromoléculaire, p.ex. une molécule oligomérique, polymérique ou dendrimérique obtenu par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone, p.ex. polyurées ou polyuréthanes le composé organique macromoléculaire étant un oligomère, un polymère ou un dendrimère de polyoxyalkylène, p.ex. PEG, PPG, PEO ou polyglycérol
[Object]
[Object]
Provided is a method of producing a nerve bundle including efficiently extending axons of neural cells.
[Object]
Provided is a method of producing a nerve bundle including efficiently extending axons of neural cells.
[Solution]
[Object]
Provided is a method of producing a nerve bundle including efficiently extending axons of neural cells.
[Solution]
Neural cells are cultivated in the presence of feeder cells including at least one type of cells selected from vascular component cells and perivascular cells.
C12M 3/00 - Appareillage pour la culture de tissus, de cellules humaines, animales ou végétales, ou de virus
A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
A hydrogen generator includes a reaction vessel, a water supply, a temperature adjustor, and a controller. The reaction vessel houses a hydrogen generating material having hydrogen generating ability. The hydrogen generating material includes a two-dimensional hydrogen boride sheet having a two-dimensional network and containing multiple negatively charged boron atoms. The controller is configured to execute a hydrogen generating mode to generate hydrogen from the hydrogen generating material and a regenerating mode to recover the hydrogen generating ability of the hydrogen generating material. The controller controls the temperature adjustor to heat the hydrogen generating material at a first predetermined temperature during the hydrogen generating mode. The controller controls the temperature adjustor to adjust the temperature of the hydrogen generating material to a second predetermined temperature and controls the water supply to supply water during the regenerating mode.
B01J 16/00 - Procédés chimiques généraux faisant réagir des liquides avec des solides non particulaires, p.ex. des matériaux en feuilles; Appareillage spécialement adapté à cet effet
B01J 19/00 - Procédés chimiques, physiques ou physico-chimiques en général; Appareils appropriés
B01J 19/24 - Réacteurs fixes sans élément interne mobile
B01J 19/32 - Eléments de remplissage en forme de grille ou d'éléments composés de plusieurs pièces pour constituer une unité ou un module dans l'appareil de transfert de chaleur ou de matière
C01B 3/08 - Production d'hydrogène ou de mélanges gazeux contenant de l'hydrogène par réaction de composés inorganiques comportant un hydrogène lié électropositivement, p.ex. de l'eau, des acides, des bases, de l'ammoniac, avec des agents réducteurs inorganiques avec des métaux
60.
Distributed data integration device, distributed data integration method, and program
A distributed data integration device includes an acquisition unit configured to acquire, for a piece of analysis target data, an anchor data intermediate representation and an analysis target intermediate representation, the anchor data intermediate representation being an intermediate representation obtained by converting anchor data by a first function, the anchor data being data commonly used in integration of a plurality of the pieces of analysis target data that are distributed, the analysis target intermediate representation being an intermediate representation obtained by converting the analysis target data by the first function, an anchor data conversion unit configured to convert, for the piece of analysis target data, a plurality of the anchor data intermediate representations by a second function, a calculation unit configured to calculate, for the piece of analysis target data, the second function that minimizes a difference between the plurality of the anchor data intermediate representations, and an analysis target data conversion unit configured to convert, for the piece of analysis target data, the analysis target intermediate representation by the second function.
G06F 21/62 - Protection de l’accès à des données via une plate-forme, p.ex. par clés ou règles de contrôle de l’accès
G06V 30/414 - Extraction de la structure géométrique, p.ex. arborescence; Découpage en blocs, p.ex. boîtes englobantes pour les éléments graphiques ou textuels
Provided is a plant pathogen control agent that is used to control plant pathogens on plants and is a novel method for using cellulose nanofibers. The plant pathogen control agent is a plant pathogen control agent containing plant-derived cellulose nanofibers as active ingredient, in which a surface of a nanofiber-coated layer to be formed by sparging or spraying the plant pathogen control agent onto the foliage or the stems of the plants and then by drying the plant pathogen control agent has hydrophilicity. Examples of the cellulose nanofibers include a plant-derived nanofiber material selected from the group consisting of gramineous plants, broadleaf trees, and needleleaf trees. Examples of the plants to be an application target include cabbage plants, soybean plants, tomato plants, tobacco plants, or coffee tree seedlings. In addition, examples of the plant pathogens to be a control target include causative bacterium, rust fungi, or pathogenic fungi.
A01N 43/16 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des composés hétérocycliques comportant des cycles avec un ou plusieurs atomes d'oxygène ou de soufre comme uniques hétéro-atomes du cycle avec un hétéro-atome des cycles à six chaînons avec l'oxygène comme hétéro-atome du cycle
A01N 25/34 - Formes façonnées, p.ex. feuilles, non prévues dans l'un quelconque des autres sous-groupes du présent groupe principal
A01P 1/00 - Désinfectants; Composés antimicrobiens ou leurs mélanges
62.
METHOD FOR MANUFACTURING CARBON NANOTUBE, METHOD FOR MANUFACTURING CARBON NANOTUBE ASSEMBLED WIRE, METHOD FOR MANUFACTURING CARBON NANOTUBE ASSEMBLED WIRE BUNDLE, CARBON NANOTUBE MANUFACTURING APPARATUS, CARBON NANOTUBE ASSEMBLED WIRE MANUFACTURING APPARATUS, AND CARBON NANOTUBE ASSEMBLED WIRE BUNDLE MANUFACTURING APPARATUS
A method for manufacturing a carbon nanotube includes: a growing step of growing a carbon nanotube from a catalyst particle by supplying a carbon-containing gas to the catalyst particle in a suspended state; and a drawing step of drawing the carbon nanotube by applying a tensile force to the carbon nanotube in a suspended state.
B01J 8/06 - Procédés chimiques ou physiques en général, conduits en présence de fluides et de particules solides; Appareillage pour de tels procédés avec des particules immobiles, p.ex. dans des lits fixes les particules solides étant disposées dans des tubes
H01B 1/06 - Conducteurs ou corps conducteurs caractérisés par les matériaux conducteurs utilisés; Emploi de matériaux spécifiés comme conducteurs composés principalement d'autres substances non métalliques
H01B 1/16 - Matériau conducteur dispersé dans un matériau inorganique non conducteur le matériau conducteur comportant des métaux ou des alliages
64.
INTERACTIVE INFORMATION TRANSFER SYSTEM, INTERACTIVE INFORMATION TRANSFER METHOD, AND INFORMATION TRANSFER SYSTEM
As an expert gives instructions to cause movements of their own hands transferred directly as tactile force sense while perceiving surrounding information of a collaborator on a real-time basis and watching the collaborator's line-of-sight end and movements of the collaborator's hands, the collaborator indirectly receives the instructions of the expert's manual skills, which are the expert's tacit knowledge, on a real-time basis while sharing realistic sensations with the expert who is at a remote location when the collaborator performs an act of working with their own hands.
A61B 90/00 - Instruments, outillage ou accessoires spécialement adaptés à la chirurgie ou au diagnostic non couverts par l'un des groupes , p.ex. pour le traitement de la luxation ou pour la protection de bords de blessures
A61B 34/00 - Chirurgie assistée par ordinateur; Manipulateurs ou robots spécialement adaptés à l’utilisation en chirurgie
65.
BODY FLUID ANTIBODY BIOMARKER FOR HIGHLY SENSITIVE DETECTION OF RISK OF ONSET OF CEREBRAL INFARCTION
NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY (Japon)
OSAKA UNIVERSITY (Japon)
Inventeur(s)
Kuroda, Hideyuki
Nakamura, Rika
Tomiyoshi, Go
Hiwasa, Takaki
Yamagishi, Kazumasa
Tsugane, Shoichiro
Sawada, Norie
Iso, Hiroyasu
Abrégé
The present invention provides a method for acquiring data relating to the onset of cerebral infarction, characterized in that the method includes determining the level of an antibody to DIDO1 protein or a portion thereof, and/or the level of an antibody to CPSF2 protein or a portion thereof, the antibody or antibodies being present in a body fluid sample collected from a living body. The invention also provides a kit for acquiring data for carrying out the method of the present invention. The invention can accurately discern signs linked to the onset of cerebral infarction.
G01N 33/68 - Analyse chimique de matériau biologique, p.ex. de sang ou d'urine; Test par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligands; Test immunologique faisant intervenir des protéines, peptides ou amino-acides
A first drive unit, in a state where a top end of a tubular joint is interposed into a chest of a target person and is located at a lower heart part, pushes a diaphragm out from the top end of the tubular joint while pressing a gas into the diaphragm, and simultaneously causes the diaphragm to start flexing to cover and wrap the lower heart part, and then stops pressing the gas into the diaphragm at a time point where compression balloons are positioned at atriums and ventricles of a heart, respectively; and second drive units support a pumping function of the heart by alternately repeating an ejecting operation to fill each of the compression balloons with a fluid and cause each compression balloon to expand and an absorbing operation to cause each compression balloon to discharge the fluid and contract.
A61M 60/191 - Pompes ou dispositifs de pompage implantables, c.-à-d. que le sang est pompé à l’intérieur du corps du patient implantables dans ou sur le cœur, ou autour du cœur agissant mécaniquement sur l’extérieur du cœur natif du patient, p.ex. structures compressives placées autour du cœur
67.
Carbon nanotube composite assembled wire, heat-treated body of carbon nanotube composite assembled wire, method for manufacturing carbon nanotube composite assembled wire, and method for manufacturing heat-treated body of carbon nanotube composite assembled wire
A carbon nanotube composite assembled wire is a carbon nanotube composite assembled wire including a plurality of carbon nanotube composites, each of the plurality of carbon nanotube composites including one carbon nanotube and an amorphous carbon-containing layer that coats the carbon nanotube, the carbon nanotube having a D/G ratio of 0.1 or less, the D/G ratio being a ratio of a peak intensity of a D band to a peak intensity of a G band in Raman spectroscopic analysis with a wavelength of 532 nm, each of the plurality of carbon nanotube composites being fibrous and having a diameter of 0.1 μm or more and 50 μm or less, the plurality of carbon nanotube composites being oriented in a longitudinal direction of the carbon nanotube composite assembled wire.
H01B 1/04 - Conducteurs ou corps conducteurs caractérisés par les matériaux conducteurs utilisés; Emploi de matériaux spécifiés comme conducteurs composés principalement soit de compositions à base de carbone-silicium, soit de carbone soit de silicium
H01B 13/00 - Appareils ou procédés spécialement adaptés à la fabrication de conducteurs ou câbles
B82Y 30/00 - Nanotechnologie pour matériaux ou science des surfaces, p.ex. nanocomposites
B82Y 40/00 - Fabrication ou traitement des nanostructures
68.
Data compressor, data decompressor, and data compression/decompression system
A technique to prevent a retrieving process of a conversion rule from taking a longer time is provided. Provided are a conversion table in which a predetermined number of entry regions capable of storing a mapping between first data and second data smaller in size than the first data are included, the predetermined number of entry regions are divided into a plurality of bank regions, and each of the plurality of bank regions includes entry regions smaller in number than the predetermined number, a determination unit configured to uniquely determine, among the plurality of bank regions, a bank region corresponding to the first data, and a processing unit configured to search entry regions of the determined bank region the predetermined number of times each or a smaller number of times than the predetermined number each, output, when the second data corresponding to the first data is stored, the second data, and when the second data corresponding to the first data is not stored, register the second data corresponding to the first data in an entry region in which another piece of second data is not stored and output the first data.
H03M 7/00 - Conversion d'un code, dans lequel l'information est représentée par une séquence donnée ou par un nombre de chiffres, en un code dans lequel la même information est représentée par une séquence ou par un nombre de chiffres différents
H03M 7/30 - Compression; Expansion; Elimination de données inutiles, p.ex. réduction de redondance
A driving simulator with which a person with impaired vision can accurately recognize danger at driving and influence of a visual field loss on driving can be experienced is provided. A controller (6) of this driving simulator (1) executes simulated video display control to store visual field loss information data of a user M and simulated video data and display the simulated video data on a screen (8). The controller (6) stores association video data in which a viewpoint O of the user M, the visual field loss information data, and a video of an object in the simulated video data are associated with one another being centered at the viewpoint O of the user M in an identical video during execution of the simulated video display control, and performs playback display of the association video data on the screen (8) after end of the simulated video display control.
G09B 9/052 - Simulateurs pour l'enseignement ou l'entraînement pour l'enseignement de la conduite des véhicules ou autres moyens de transport pour l'enseignement de la conduite des véhicules terrestres caractérisés par des moyens pour enregistrer ou mesurer les performances de l'élève
H04N 21/238 - Interfaçage de la voie descendante du réseau de transmission, p.ex. adaptation du débit de transmission d'un flux vidéo à la bande passante du réseau; Traitement de flux multiplexés
0), the visibility (V), and the phase (φ) through variable approximation of an image. The absorption, the visibility, and the phase are obtained, based on at least one measurement image.
G01N 23/041 - Imagerie en contraste de phase, p.ex. en utilisant des interféromètres à réseau
G01N 23/083 - Recherche ou analyse des matériaux par l'utilisation de rayonnement [ondes ou particules], p.ex. rayons X ou neutrons, non couvertes par les groupes , ou en transmettant la radiation à travers le matériau et mesurant l'absorption le rayonnement consistant en rayons X
A61B 6/00 - Appareils pour diagnostic par radiations, p.ex. combinés avec un équipement de thérapie par radiations
71.
Carbon nanotube composite, method for manufacturing the same, and method for manufacturing refined carbon nanotube
A carbon nanotube composite is a carbon nanotube composite including one carbon nanotube and an amorphous carbon-containing layer that coats the carbon nanotube, the carbon nanotube having a D/G ratio of 0.1 or less, the D/G ratio being a ratio of a peak intensity of a D band to a peak intensity of a G band in Raman spectroscopic analysis with a wavelength of 532 nm, the carbon nanotube composite being fibrous and having a diameter of 0.1 μm or more and 50 μm or less.
A wearable gait detection device, a walking ability improvement system and a wearable gait detection system detect manifestation in a brain based on the wearer's gait and preventive measures. A load measurement part measures a load of a sole of the wearer's feet, a foot movement detection part at the shoes detects acceleration and/or angular velocity during feet movement, a centroid position calculation part calculates a centroid position of the feet based on changes in measured load, a movement locus calculation part calculates a movement locus of the feet based on acceleration and/or angular velocity detected by the foot movement detection part, a manifestation recognition part recognizes manifestation in the brain according to a specificity of centroid fluctuation of the feet based on the calculated centroid position and movement locus of the feet, and a sensory output part feeds back a sensation to the wearer based on a recognition result.
A61B 5/11 - Mesure du mouvement du corps entier ou de parties de celui-ci, p.ex. tremblement de la tête ou des mains ou mobilité d'un membre
A61B 5/00 - Mesure servant à établir un diagnostic ; Identification des individus
A61B 5/103 - Dispositifs de mesure pour le contrôle de la forme, du dessin, de la dimension ou du mouvement du corps ou de parties de celui-ci, à des fins de diagnostic
A physiological state evaluation apparatus contacts an external auditory pore when mounted in a subject's auricle. The evaluation apparatus: collects sound vibrations generated from a larynx and a pharynx via a cartilage region of the external auditory pore; optically detects a pulsatory motion of blood through blood vessels and measures pulse rate and blood oxygen saturation, on the basis of a change in optical intensity caused by the pulsatory motion; detects brain waves and eye movements using a pair of conductive electrodes for detecting electric potentials of right and left external auditory pore surfaces; detects, sound quality, number of times, tidal volume, and rhythm of the subject's breaths on the basis of the acoustic signal; and evaluates a health condition of the subject while sleeping on the basis of the respiratory condition, the pulse rate and the blood oxygen saturation, and the brain waves and the eye movements.
A61B 5/0205 - Evaluation simultanée de l'état cardio-vasculaire et de l'état d'autres parties du corps, p.ex. de l'état cardiaque et respiratoire
A61B 5/11 - Mesure du mouvement du corps entier ou de parties de celui-ci, p.ex. tremblement de la tête ou des mains ou mobilité d'un membre
A61B 5/291 - Détection, mesure ou enregistrement de signaux bioélectriques ou biomagnétiques du corps ou de parties de celui-ci Électrodes bioélectriques à cet effet spécialement adaptées à des utilisations particulières pour l’électroencéphalographie [EEG]
A61B 5/369 - Modalités, c. à d. méthodes diagnostiques spécifiques Électroencéphalographie [EEG]
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p.ex. de la concentration des gaz dans le sang, de la valeur du pH du sang
A61B 5/00 - Mesure servant à établir un diagnostic ; Identification des individus
A fusion protein including a Cas9 protein and a modifying peptide that modifies the Cas9 protein, in which the modifying peptide includes: a peptide composed of the amino acid sequence described in SEQ ID NO: 29; or a peptide composed of an amino acid sequence in which one or several amino acids are deleted, substituted, or added in the amino acid sequence described in SEQ ID NO: 29 and having activity to localize the Cas9 protein in the nucleus by forming a fusion protein with the Cas9 protein.
C07K 14/47 - Peptides ayant plus de 20 amino-acides; Gastrines; Somatostatines; Mélanotropines; Leurs dérivés provenant d'humains provenant de vertébrés provenant de mammifères
Problem to be Solved
A traverse that is percutaneously provided and a surgical instrument for percutaneously providing the transverse are provided.
Solution
A rod 10 is placed in each of two rod openings 113, 123 and a transverse bar 130 is inserted in two bar holes 111, 121. Set screws 140, 150 are screwed in screw holes 114, 124. The set screws 140, 150 press the transverse bar 130, thereby restraining the transverse bar 130 in the longitudinal direction. Since portions of the bar holes 111, 121 adjoin the rod openings 113, 123, the pressed transverse bar 130 contacts the rods 10 and pushes the rods 10 against the rod openings 113, 123. A protrusion 127 engages with the rods 10 to restrain hooks 110, 120 in the longitudinal direction and circumferential direction of the rods 10.
A61B 17/70 - Dispositifs de mise en position ou de stabilisation de la colonne vertébrale
A61B 17/16 - Ostéoclastes; Forets ou ciseaux pour os; Trépans
A61B 90/00 - Instruments, outillage ou accessoires spécialement adaptés à la chirurgie ou au diagnostic non couverts par l'un des groupes , p.ex. pour le traitement de la luxation ou pour la protection de bords de blessures
76.
PROTEIN EXPRESSION SYSTEM IN PLANT CELL AND USE THEREOF
An expression system is provided, including a first nucleic acid fragment containing a long intergenic region (LIR) derived from geminivirus, a small intergenic region (SIR) derived from geminivirus, and an expression cassette of a target protein linked between the LIR and the SIR and a second nucleic acid fragment containing an expression cassette of a Rep/RepA protein derived from geminivirus, in which the expression cassette of the target protein includes a promoter, a nucleic acid fragment encoding the target protein, and two or more linked terminators in this order.
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (USA)
Inventeur(s)
Nagase, Hiroshi
Saitoh, Tsuyoshi
Yanagisawa, Masashi
Irukayama, Yoko
Abrégé
The present invention aims to provide a novel low-molecular-weight compound showing an orexin receptor agonist activity and expected to be useful as a prophylactic or therapeutic agent for narcolepsy and the like. The present invention provides a compound represented by the formula (I):
wherein each symbol is as described in the description, or a pharmaceutically acceptable acid addition salt thereof, which has an orexin receptor agonist activity, and an orexin receptor agonist containing the compound or a pharmaceutically acceptable acid addition salt thereof.
In a scanning imaging apparatus of some aspect examples, a scanner applies an optical scan to a sample to acquire data. A scan controller controls the scanner to sequentially apply, to the sample, pattern scans according to a two-dimensional pattern including cycles. A movement unit relatively moves a scan area corresponding to the two-dimensional pattern and the sample. A movement controller controls the movement unit such that cycles in first and second scans of the pattern scans cross each other. An image constructing unit constructs an image based on data acquired under controls performed by the scan controller and the movement controller. The scan controller and the movement controller perform controls of the scanner and the movement unit respectively such that first and second cycles in a pattern scan cross each other at least at one point.
A61B 3/00 - Appareils pour l'examen optique des yeux; Appareils pour l'examen clinique des yeux
A61B 3/10 - Appareils pour l'examen optique des yeux; Appareils pour l'examen clinique des yeux du type à mesure objective, c. à d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient
G01B 9/02091 - Interféromètres tomographiques, p.ex. à cohérence optique
79.
Object identification device and object identification method
Provided are an object identification device and an object identification method in which objects can be easily identified. The object identification device is provided with a pixel group extraction unit which scans, in units of the image area, an X-ray transferred image obtained from an imaging unit which performs X-ray imaging to an item to be inspected that is supplied, and extracts a plurality of pixel groups including characteristics of a shape of at least a part of the item to be inspected, and a determination unit which determines, with regard to the plurality of pixel groups extracted by the pixel group extraction unit, whether the item to be inspected corresponds to the object by executing all of the series of mappings related to an angle of an n direction by using each of the weight parameters based on the data group read from the memory unit.
G06V 10/44 - Extraction de caractéristiques locales par analyse des parties du motif, p.ex. par détection d’arêtes, de contours, de boucles, d’angles, de barres ou d’intersections; Analyse de connectivité, p.ex. de composantes connectées
G01N 23/04 - Recherche ou analyse des matériaux par l'utilisation de rayonnement [ondes ou particules], p.ex. rayons X ou neutrons, non couvertes par les groupes , ou en transmettant la radiation à travers le matériau et formant des images des matériaux
G01N 23/083 - Recherche ou analyse des matériaux par l'utilisation de rayonnement [ondes ou particules], p.ex. rayons X ou neutrons, non couvertes par les groupes , ou en transmettant la radiation à travers le matériau et mesurant l'absorption le rayonnement consistant en rayons X
G06K 9/62 - Méthodes ou dispositions pour la reconnaissance utilisant des moyens électroniques
G08B 3/10 - Systèmes de signalisation audible; Systèmes d'appel sonore de personnes utilisant une transmission électromagnétique
G08B 5/36 - Systèmes de signalisation optique, p.ex. systèmes d'appel de personnes, indication à distance de l'occupation de sièges utilisant une transmission électromécanique utilisant des sources de lumière visible
80.
Musicality information provision method, musicality information provision apparatus, and musicality information provision system
A musicality information provision method includes acquiring first performance data from a performance of a given composition, calculating, with respect to a combination of a plurality of parameters indicating musicality, which are included in the first performance data, respective distances between the first performance data and a plurality of sets of second performance data that are acquired from performances of the given composition and that are compared with the first performance data, and outputting determination information for determining the musicality of the first performance data, the determination information including information indicating the distances.
[Problem] Learning of object operation skills robust against variation of conditions is implemented.
[Solution] A behavior estimation apparatus 100 includes a collection unit 200 configured to collect skill data obtained when a slave robot is operated under a plurality of different conditions by using a bilateral system capable of operating the slave robot via a master robot through bidirectional control between the master robot and the slave robot. The behavior estimation apparatus 100 further includes a behavior estimation device 300 configured to estimate a command value for causing the slave robot 520 to automatically behave, based on the skill data collected by the collection unit 200 and a response output from the slave robot 520.
B25J 3/00 - Manipulateurs de type à commande asservie, c. à d. manipulateurs dans lesquels l'unité de commande et l'unité commandée exécutent des mouvements correspondants dans l'espace
In order to develop tools and methods useful in a variety of applications, including the research and development of medical treatments which involve the modification of collagen protein and use of the same, the present invention provides a modified collagen protein expressed in a transformed cell and capable of forming collagen fibers outside of the cell, wherein the transformation is performed by introducing, into the cell, polynucleotides coding the modified collagen protein.
C12N 15/63 - Introduction de matériel génétique étranger utilisant des vecteurs; Vecteurs; Utilisation d'hôtes pour ceux-ci; Régulation de l'expression
C12N 5/10 - Cellules modifiées par l'introduction de matériel génétique étranger, p.ex. cellules transformées par des virus
A61K 38/39 - Peptides du tissu connectif, p.ex. collagène, élastine, laminine, fibronectine, vitronectine, globuline insoluble à froid [CIG]
C12N 15/85 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules animales
83.
Image display device, image display method, and image display system
An image display device acquires positional information including a distance between at least one eye of an observer and an image display surface, and corrects, based on the acquired positional information, a relative positional relationship between slit areas and an image displayed on the image display surface, by using a width smaller than the width of one subpixel as a minimum correction unit.
G02B 30/31 - Systèmes ou appareils optiques pour produire des effets tridimensionnels [3D], p.ex. des effets stéréoscopiques en fournissant des première et seconde images de parallaxe à chacun des yeux gauche et droit d’un observateur du type autostéréoscopique comprenant des barrières de parallaxe comprenant des barrières actives de parallaxe
H04N 13/317 - Reproducteurs d’images pour visionnement sans avoir recours à des lunettes spéciales, c. à d. utilisant des affichages autostéréoscopiques la parallaxe provenant d’éléments optiques en biais
G02B 30/32 - Systèmes ou appareils optiques pour produire des effets tridimensionnels [3D], p.ex. des effets stéréoscopiques en fournissant des première et seconde images de parallaxe à chacun des yeux gauche et droit d’un observateur du type autostéréoscopique comprenant des barrières de parallaxe caractérisés par la géométrie de barrières de parallaxe, p.ex. barrières échelonnées, réseaux de parallaxes en biais ou réseaux de parallaxes de formes ou de tailles variables
G02B 30/22 - Systèmes ou appareils optiques pour produire des effets tridimensionnels [3D], p.ex. des effets stéréoscopiques en fournissant des première et seconde images de parallaxe à chacun des yeux gauche et droit d’un observateur du type stéréoscopique
A data creation method includes: an autofluorescence data generation step of placing a focus of light having a predetermined wavelength at one set of coordinates on a predetermined focal plane, irradiating a sample positioned at the set of coordinates with excitation light containing the light to obtain autofluorescence emitted from the sample, and generating autofluorescence data including intensity data and/or spectrum data of the autofluorescence; a reflected light data generation step of irradiating the set of coordinates on the predetermined focal plane with illumination light to obtain reflected light scattered by the sample, and generating intensity data of the reflected light; and a correspondence data creation step of creating correspondence data associating the autofluorescence data and the reflected light data on the set of coordinates on the predetermined focal plane.
G01N 33/50 - Analyse chimique de matériau biologique, p.ex. de sang ou d'urine; Test par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligands; Test immunologique
A motion assisting apparatus includes a multijoint structure having links in series rotatably connected in a relative manner, the links being integrally deformed in a bendable manner, a linear member inserted through each of the links, wherein one end is fixed to the link in front and another end is elongated via the link in rear, a sliding/holding part which fixes an elongated portion of the linear member, and slidably guides the rear link in a connecting direction between each of the links, a drive unit which drives the rear link to slide toward the sliding/holding part and causes the multijoint structure, through which the linear member has been inserted, to engage in an extending or flexing motion, and a control unit which drive-controls the drive unit so that a sliding direction, a sliding speed and a sliding position of the rear link will become an intended state.
An upper limb motion support apparatus and an upper limb motion support system which are capable of significantly improving the enhancement of an operator's work efficiency and the reduction of their workload are proposed. A controller which causes an articulated arm and an end effector to perform three-dimensional motion according to the operator's intention based on a biological signal acquired by a biological signal detection unit causes the articulated arm and the end effector to perform cooperative motion in conjunction with the operator's upper limb motion by referring to content recognized by an upper limb motion recognition unit.
A non-human animal is provided in which blood cells have a first genetic background, cells other than blood cells have a second genetic background, the first genetic background is different from the second genetic background, and the second genetic background is a genetic mutation that does not form hematopoietic stem cells.
A carbon nanostructure producing method includes a growth step in which a plurality of catalyst particles in close contact with each other are separated in a flow of a carbon-containing gas so as to grow carbon nanotubes between the plurality of catalyst particles, and an elongation step in which the carbon nanotube is elongated by a wind pressure of the carbon-containing gas with at least one of the catalyst particles being retained.
A walking training system and walking training machine capable of remarkably enhancing the effect of improving an independent walking function are proposed. When a subject having a lower limb functional disorder performs walking training, the degree of dependency on upper limbs can be evaluated by enabling the subject to recognize transitional reductions of a load on a holding part(s) by feeding back the transitional reductions of the load as a sense to feel them.
A61B 5/00 - Mesure servant à établir un diagnostic ; Identification des individus
G16H 20/30 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p.ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies ou des activités physiques, p.ex. la physiothérapie, l’acupression ou les exercices
G16H 50/50 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicales; TIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour la simulation ou la modélisation des troubles médicaux
G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicales; TIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santé; TIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
A61B 5/103 - Dispositifs de mesure pour le contrôle de la forme, du dessin, de la dimension ou du mouvement du corps ou de parties de celui-ci, à des fins de diagnostic
A61H 3/00 - Appareils pour aider des personnes handicapées à marcher
A61H 3/04 - Appuis à roues pour aider les personnes handicapées à marcher
A63B 22/02 - Appareils d'exercice spécialement adaptés à l'entraînement du système cardio-vasculaire, pour exercer l'agilité ou la coordination des mouvements avec des tapis roulants sans fin
90.
Detection of citrullinated inter-alpha-trypsin inhibitor heavy chain 4 (ITIH4)
This invention provides a method for diagnosis of rheumatoid arthritis of a subject, a method for assisting diagnosis of rheumatoid arthritis, and a method for monitoring disease activity of rheumatoid arthritis and/or therapeutic effects of an agent for rheumatoid arthritis, comprising detecting citrullination of an arginine residue of the inter-α-trypsin inhibitor heavy chain (ITIH) 4 in a biological sample obtained from the subject. This invention also provides a citrullinated protein derived from the protein having the amino acid sequence as shown in SEQ ID NO: 1 or 5 by modification of arginine 438 into citrulline or a fragment thereof, an antibody binding to such citrullinated protein, and an agent for diagnosis of rheumatoid arthritis comprising such antibody.
G01N 33/564 - Tests immunologiques; Tests faisant intervenir la formation de liaisons biospécifiques; Matériaux à cet effet pour complexes immunologiques préexistants ou maladies auto-immunes
C07K 16/38 - Immunoglobulines, p.ex. anticorps monoclonaux ou polyclonaux contre des inhibiteurs de protéase de structure peptidique
91.
Wave-activated power generation device and wave-activated power generation method
A wave-activated power generation device is disclosed. The device includes a float configured to be capable of floating in the sea; a rotor configured to generate a rotational inertial mass effect; a power generator configured to generate power based on rotation of the rotor; a first elastic body; and a drive part configured to connect the rotor with the float via the first elastic body so as to rotate the rotor along with movement of the float.
F03B 13/18 - Utilisation du mouvement relatif entre un élément déplacé par les vagues et un autre élément l'autre élément étant fixé, à au moins un point, par rapport au fond ou au bord de la mer
92.
Therapeutic agent for tumors identified by phosphorylation of proto-oncogene protein belonging to VAV family
The present invention provides a therapeutic agent and others for various tumors including angioimmunoblastic T-cell lymphoma (AITL), which is an orphan disease. The present invention relates to a therapeutic agent and others for tumors identified by phosphorylation of a proto-oncogene protein belonging to the VAV family, which comprises dasatinib or a prodrug thereof or a pharmacologically acceptable salt thereof or a hydrate or solvate thereof as an active ingredient.
The present invention relates to a carotenoid-containing composition for use in exercise therapy for improving cognitive function, particularly exercise therapy for hippocampal neurogenesis.
A gait disorder support apparatus and gait disorder support method capable of detecting an onset sign of a gait disorder associated with motor symptoms in advance and performing motion assist are proposed. The onset sign of the gait disorder associated with the motor symptoms of a wearer is detected based on the correlation between a gait cycle and a reduction ratio of the gait cycle as compared to immediately preceding gait; and when the onset sign of the gait disorder is detected, a drive unit is controlled so that the drive unit applies assist power to a knee joint of the wearer; and on the other hand, when the onset sign of the gait disorder is not detected, the drive unit is controlled so that driving torque by the drive unit does not hinder the wearer's gait motion.
An image generation method of an interior CT includes the following steps: a step for obtaining interior CT projection data by measuring quantum beams passing through a region of interest (ROI) in an inside of photographing object in a geometrical system for CT measurement; a step for obtaining partial entire projection data by measuring quantum beams passing through an entire of said photographing object from a segment in an outside of said photographing object in said geometrical system for CT measurement; and a processing step for exactly reconstructing said ROI upon basis of said interior CT projection data obtained and said partial entire projection data.
A power generation device, comprising a fuel, an anode and a cathode, the anode comprising an enzyme that promotes oxidation of the fuel, and the power generation device containing more water when generating power than when not generating power.
H01M 8/16 - PROCÉDÉS OU MOYENS POUR LA CONVERSION DIRECTE DE L'ÉNERGIE CHIMIQUE EN ÉNERGIE ÉLECTRIQUE, p.ex. BATTERIES Éléments à combustible; Leur fabrication Éléments à combustible biochimique, c. à d. éléments dans lesquels des micro-organismes agissent comme catalyseurs
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p.ex. de la concentration des gaz dans le sang, de la valeur du pH du sang
An object tracking device includes a superimposed image creation unit configured to create a plurality of superimposed images in which each of a plurality of non-tracking object images which do not include a tracking object image feature is superimposed on a tracking object section image which includes a tracking object image feature; a discriminator creation unit configured to learn at least one of an image feature and position information of the tracking object, based on the plurality of superimposed images to create a discriminator; and a tracking object specifying unit configured to specify at least one of the image feature and the position information of the tracking object in a tracked image including the respective image features of the tracking object and an obstacle, based on the discriminator and the tracked image.
G06K 9/00 - Méthodes ou dispositions pour la lecture ou la reconnaissance de caractères imprimés ou écrits ou pour la reconnaissance de formes, p.ex. d'empreintes digitales
G06T 7/32 - Détermination des paramètres de transformation pour l'alignement des images, c. à d. recalage des images utilisant des procédés basés sur la corrélation
G06T 7/55 - Récupération de la profondeur ou de la forme à partir de plusieurs images
G06T 7/246 - Analyse du mouvement utilisant des procédés basés sur les caractéristiques, p.ex. le suivi des coins ou des segments
A61N 5/10 - Radiothérapie; Traitement aux rayons gamma; Traitement par irradiation de particules
G06K 9/62 - Méthodes ou dispositions pour la reconnaissance utilisant des moyens électroniques
98.
COPOLYMER CONTAINING CYCLIC NITROXIDE RADICAL AND TRIALKOXYSILYL IN SIDE CHAIN, AND USE THEREOF
A copolymer which includes hydrophilic and hydrophobic blocks, which can form nanoparticles in which a physiologically active substance can be efficiently packaged therein and which are stable under acidic conditions. The hydrophilic segment of the copolymer is composed of polyethylene glycol (PEG) and the hydrophobic segment is composed of polystyrene. The hydrophobic segment has a side chain, and the side chain has ends to which a cyclic nitroxide radical having a radical scavenging function and a trialkoxysilane are covalently bonded.
C08G 81/02 - Composés macromoléculaires obtenus par l'interréaction de polymères en l'absence de monomères, p.ex. polymères séquencés au moins un des polymères étant obtenu par des réactions ne faisant intervenir que des liaisons non saturées carbone-carbone
A61K 47/34 - Composés macromoléculaires obtenus par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone, p.ex. polyesters, acides polyaminés, polysiloxanes, polyphosphazines, copolymères de polyalkylène glycol o
A61K 31/4709 - Quinoléines non condensées contenant d'autres hétérocycles
A61K 31/44 - Pyridines non condensées; Leurs dérivés hydrogénés
In a networking system including a plurality of nodes connected with each other by a communication network, each node includes an abnormality discrimination unit configured, when a cumulative consumption current at the time of processing the data received from other node is out of a range (of current values estimated in advance based on an event at the other node, to discriminate the other node as an abnormal. By the networking system, the abnormality of the nodes on the network may be detected with a simple configuration.
An artificial leg motion assisting apparatus and an artificial leg motion assisting method which are capable of transmitting knee joint motive power to a commercially-available trans-femoral prosthesis without making a wearer feel a sense of discomfort. When the artificial leg motion assisting apparatus is attached to the commercially-available trans-femoral prosthesis, a control unit controls a drive unit by a specified control method on the basis of mechanical impedance adjusted by an impedance adjustment unit and transmits output of the drive unit to a knee joint coupling.